Literature DB >> 31654282

Multimodal non-invasive monitoring to apply an open lung approach strategy in morbidly obese patients during bariatric surgery.

Gerardo Tusman1, Cecilia M Acosta2, Marcos Ochoa2, Stephan H Böhm3, Emiliano Gogniat4, Jorge Martinez Arca5, Adriana Scandurra5, Matías Madorno6, Carlos Ferrando7, Fernando Suarez Sipmann8,9,10.   

Abstract

To evaluate the use of non-invasive variables for monitoring an open-lung approach (OLA) strategy in bariatric surgery. Twelve morbidly obese patients undergoing bariatric surgery received a baseline protective ventilation with 8 cmH2O of positive-end expiratory pressure (PEEP). Then, the OLA strategy was applied consisting in lung recruitment followed by a decremental PEEP trial, from 20 to 8 cmH2O, in steps of 2 cmH2O to find the lung's closing pressure. Baseline ventilation was then resumed setting open lung PEEP (OL-PEEP) at 2 cmH2O above this pressure. The multimodal non-invasive variables used for monitoring OLA consisted in pulse oximetry (SpO2), respiratory compliance (Crs), end-expiratory lung volume measured by a capnodynamic method (EELVCO2), and esophageal manometry. OL-PEEP was detected at 15.9 ± 1.7 cmH2O corresponding to a positive end-expiratory transpulmonary pressure (PL,ee) of 0.9 ± 1.1 cmH2O. ROC analysis showed that SpO2 was more accurate (AUC 0.92, IC95% 0.87-0.97) than Crs (AUC 0.76, IC95% 0.87-0.97) and EELVCO2 (AUC 0.73, IC95% 0.64-0.82) to detect the lung's closing pressure according to the change of PL,ee from positive to negative values. Compared to baseline ventilation with 8 cmH2O of PEEP, OLA increased EELVCO2 (1309 ± 517 vs. 2177 ± 679 mL) and decreased driving pressure (18.3 ± 2.2 vs. 10.1 ± 1.7 cmH2O), estimated shunt (17.7 ± 3.4 vs. 4.2 ± 1.4%), lung strain (0.39 ± 0.07 vs. 0.22 ± 0.06) and lung elastance (28.4 ± 5.8 vs. 15.3 ± 4.3 cmH2O/L), respectively; all p < 0.0001. The OLA strategy can be monitored using noninvasive variables during bariatric surgery. This strategy decreased lung strain, elastance and driving pressure compared with standard protective ventilatory settings.Clinical trial number NTC03694665.

Entities:  

Keywords:  Atelectasis; Bariatric surgery; Capnography; Lung recruitment; Morbid obesity; PEEP; Pulse oximetry

Mesh:

Year:  2019        PMID: 31654282     DOI: 10.1007/s10877-019-00405-w

Source DB:  PubMed          Journal:  J Clin Monit Comput        ISSN: 1387-1307            Impact factor:   2.502


  36 in total

1.  Kinetics of absorption atelectasis during anesthesia: a mathematical model.

Authors:  C J Joyce; A B Williams
Journal:  J Appl Physiol (1985)       Date:  1999-04

2.  Alveolar instability causes early ventilator-induced lung injury independent of neutrophils.

Authors:  Jay M Steinberg; Henry J Schiller; Jeffrey M Halter; Louis A Gatto; Hsi-Ming Lee; Lucio A Pavone; Gary F Nieman
Journal:  Am J Respir Crit Care Med       Date:  2004-01-01       Impact factor: 21.405

3.  The effects of body mass on lung volumes, respiratory mechanics, and gas exchange during general anesthesia.

Authors:  P Pelosi; M Croci; I Ravagnan; S Tredici; A Pedoto; A Lissoni; L Gattinoni
Journal:  Anesth Analg       Date:  1998-09       Impact factor: 5.108

Review 4.  The physiologic effects of pneumoperitoneum in the morbidly obese.

Authors:  Ninh T Nguyen; Bruce M Wolfe
Journal:  Ann Surg       Date:  2005-02       Impact factor: 12.969

5.  Breathing mechanics, dead space and gas exchange in the extremely obese, breathing spontaneously and during anaesthesia with intermittent positive pressure ventilation.

Authors:  G Hedenstierna; J Santesson
Journal:  Acta Anaesthesiol Scand       Date:  1976       Impact factor: 2.105

Review 6.  Ventilation strategies in obese patients undergoing surgery: a quantitative systematic review and meta-analysis.

Authors:  M Aldenkortt; C Lysakowski; N Elia; L Brochard; M R Tramèr
Journal:  Br J Anaesth       Date:  2012-10       Impact factor: 9.166

7.  Atelectasis causes alveolar injury in nonatelectatic lung regions.

Authors:  Shinya Tsuchida; Doreen Engelberts; Vanya Peltekova; Natalie Hopkins; Helena Frndova; Paul Babyn; Colin McKerlie; Martin Post; Paul McLoughlin; Brian P Kavanagh
Journal:  Am J Respir Crit Care Med       Date:  2006-05-04       Impact factor: 21.405

8.  The effects of tidal volume and respiratory rate on oxygenation and respiratory mechanics during laparoscopy in morbidly obese patients.

Authors:  Juraj Sprung; David G Whalley; Tommaso Falcone; William Wilks; James E Navratil; Denis L Bourke
Journal:  Anesth Analg       Date:  2003-07       Impact factor: 5.108

9.  Respiratory restriction and elevated pleural and esophageal pressures in morbid obesity.

Authors:  Negin Behazin; Stephanie B Jones; Robert I Cohen; Stephen H Loring
Journal:  J Appl Physiol (1985)       Date:  2009-11-12

10.  Intra-abdominal hypertension and the abdominal compartment syndrome: updated consensus definitions and clinical practice guidelines from the World Society of the Abdominal Compartment Syndrome.

Authors:  Andrew W Kirkpatrick; Derek J Roberts; Jan De Waele; Roman Jaeschke; Manu L N G Malbrain; Bart De Keulenaer; Juan Duchesne; Martin Bjorck; Ari Leppaniemi; Janeth C Ejike; Michael Sugrue; Michael Cheatham; Rao Ivatury; Chad G Ball; Annika Reintam Blaser; Adrian Regli; Zsolt J Balogh; Scott D'Amours; Dieter Debergh; Mark Kaplan; Edward Kimball; Claudia Olvera
Journal:  Intensive Care Med       Date:  2013-05-15       Impact factor: 17.440

View more
  2 in total

1.  Positive end-expiratory pressure individualization guided by continuous end-expiratory lung volume monitoring during laparoscopic surgery.

Authors:  Gerardo Tusman; Mats Wallin; Cecilia Acosta; Bruno Santanera; Facundo Portela; Federico Viotti; Nora Fuentes; Magnus Hallbäck; Fernando Suarez-Sipmann
Journal:  J Clin Monit Comput       Date:  2021-12-29       Impact factor: 1.977

Review 2.  What is new in respiratory monitoring?

Authors:  Dan S Karbing; Steffen Leonhardt; Gaetano Perchiazzi; Jason H T Bates
Journal:  J Clin Monit Comput       Date:  2022-05-13       Impact factor: 1.977

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.